|
BOSTON, MA–September 27, 2011–Stonebridge Associates’ Mitch Briskin will serve as a panelist on “The State of MedTech Company Investments” at the 13th Annual MedTech Investors Conference, taking place Thursday, October 21, 2011 at UMass Boston’s Campus Center. The panel discussion will focus on current market dynamics affecting medical technology investing.
Sponsored by the Massachusetts Medical Device Industry Council, the MedTech Investors conference will feature presentations from more than 20 organizations, ranging from start-ups to public companies. The conference also features results from a survey of the region’s venture capitalists, as well as a luncheon presentation by Cam Neely, President of the Boston Bruins.
For more information or to register, please visit: http://www.massmedic.com/events/medtech-investors-conference-2011/
Mitch can be reached at mbriskin@stonebr.com or 617-357-1770.
|
Stonebridge Associates specializes in providing M&A, divestiture, private placement, and strategic financial advisory services to middle market and emerging growth companies. Applying a wealth of industry experience and structuring expertise to every engagement, Stonebridge Associates develops creative solutions to help clients achieve superior outcomes. Since 1986, Stonebridge has closed over $3 billion in private financings and advised on over 300 M&A transactions and advisory assignments. Member FINRA/SIPC.
|
Connecting to Facebook